U
CEL

UBS’s Cellcom Israel, Ltd. CEL Stock Holding History

UBS’s Portfolio CEL Stock Details CEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$5K Sell
500
-4,400
-90% -$52.2K ﹤0.01% 9513
2014
Q2 		$59K Hold
4,900
– – ﹤0.01% 6664
2014
Q1 		$68K Buy
+4,900
New +$63.1K ﹤0.01% 6453
2013
Q4 		– Sell
-400
Closed -$4K – 10919
2013
Q3 		$4K Sell
400
-900
-69% -$9.65K ﹤0.01% 9616
2013
Q2 		$12K Buy
+1,300
New +$11.8K ﹤0.01% 8468

Other funds holding CEL

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
QBFM
QS Batterymarch Financial Management New York $3.78B AUM 22.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS's CEL Position: Q3 2014 in Review

UBS increased its Cellcom Israel, Ltd. (CEL) stake by 1,228% in Q3 2014, buying an estimated $1.06M and bringing the position to 96,689 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #3525.

UBS first reported a position in CEL in Q2 2013 and has held it in 6 quarters since. The position peaked at $4.36M in Q2 2013. 44 funds tracked by Wall St. Rank hold CEL as of Q3 2014.

  • UBS held 96,689 shares of Cellcom Israel, Ltd. worth $1.06M as of Q3 2014.
  • UBS bought 89,407 Cellcom Israel, Ltd. shares in Q3 2014, an estimated $1.06M.
  • Cellcom Israel, Ltd. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3525 holding.
  • UBS first reported a position in Cellcom Israel, Ltd. in Q2 2013 and has held it in 6 quarters since.
  • UBS's Cellcom Israel, Ltd. position peaked at $4.36M in Q2 2013.
  • 44 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.